Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$1.66 - $2.79 $1,019 - $1,713
-614 Reduced 5.75%
10,070 $17,000
Q2 2022

Aug 12, 2022

SELL
$1.44 - $3.98 $1,969 - $5,444
-1,368 Reduced 11.35%
10,684 $18,000
Q1 2022

May 11, 2022

BUY
$2.97 - $5.2 $2,114 - $3,702
712 Added 6.28%
12,052 $43,000
Q4 2021

Feb 08, 2022

SELL
$4.99 - $7.46 $35,833 - $53,570
-7,181 Reduced 38.77%
11,340 $57,000
Q3 2021

Nov 02, 2021

SELL
$7.16 - $9.69 $529 - $717
-74 Reduced 0.4%
18,521 $133,000
Q2 2021

Aug 11, 2021

SELL
$6.23 - $10.03 $13,674 - $22,015
-2,195 Reduced 10.56%
18,595 $172,000
Q1 2021

May 14, 2021

SELL
$8.81 - $16.96 $44,842 - $86,326
-5,090 Reduced 19.67%
20,790 $193,000
Q4 2020

Feb 12, 2021

SELL
$8.5 - $12.85 $261,026 - $394,610
-30,709 Reduced 54.27%
25,880 $229,000
Q3 2020

Nov 04, 2020

BUY
$9.57 - $27.05 $183,744 - $519,360
19,200 Added 51.35%
56,589 $656,000
Q2 2020

Jul 17, 2020

BUY
$7.14 - $31.69 $65,588 - $291,104
9,186 Added 32.57%
37,389 $1.01 Million
Q1 2020

Apr 21, 2020

BUY
$2.98 - $14.09 $84,044 - $397,380
28,203 New
28,203 $210,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $496M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.